B

Brain+ A/S
CSE:BRAINP

Watchlist Manager
Brain+ A/S
CSE:BRAINP
Watchlist
Price: 0.102 DKK 6.25% Market Closed
Market Cap: 17.5m DKK
Have any thoughts about
Brain+ A/S?
Write Note

Intrinsic Value

BRAINP's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BRAINP stock under the Base Case scenario is 0.06 DKK. Compared to the current market price of 0.102 DKK, Brain+ A/S is Overvalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BRAINP Intrinsic Value
0.06 DKK
Overvaluation 41%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Brain+ A/S

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BRAINP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BRAINP?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Brain+ A/S

Provide an overview of the primary business activities
of Brain+ A/S.

What unique competitive advantages
does Brain+ A/S hold over its rivals?

What risks and challenges
does Brain+ A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Brain+ A/S.

Provide P/S
for Brain+ A/S.

Provide P/E
for Brain+ A/S.

Provide P/OCF
for Brain+ A/S.

Provide P/FCFE
for Brain+ A/S.

Provide P/B
for Brain+ A/S.

Provide EV/S
for Brain+ A/S.

Provide EV/GP
for Brain+ A/S.

Provide EV/EBITDA
for Brain+ A/S.

Provide EV/EBIT
for Brain+ A/S.

Provide EV/OCF
for Brain+ A/S.

Provide EV/FCFF
for Brain+ A/S.

Provide EV/IC
for Brain+ A/S.

Compare the intrinsic valuations
of Brain+ A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Brain+ A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Brain+ A/S compared to its peers.

Compare the P/E ratios
of Brain+ A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Brain+ A/S with its peers.

Analyze the financial leverage
of Brain+ A/S compared to its main competitors.

Show all profitability ratios
for Brain+ A/S.

Provide ROE
for Brain+ A/S.

Provide ROA
for Brain+ A/S.

Provide ROIC
for Brain+ A/S.

Provide ROCE
for Brain+ A/S.

Provide Gross Margin
for Brain+ A/S.

Provide Operating Margin
for Brain+ A/S.

Provide Net Margin
for Brain+ A/S.

Provide FCF Margin
for Brain+ A/S.

Show all solvency ratios
for Brain+ A/S.

Provide D/E Ratio
for Brain+ A/S.

Provide D/A Ratio
for Brain+ A/S.

Provide Interest Coverage Ratio
for Brain+ A/S.

Provide Altman Z-Score Ratio
for Brain+ A/S.

Provide Quick Ratio
for Brain+ A/S.

Provide Current Ratio
for Brain+ A/S.

Provide Cash Ratio
for Brain+ A/S.

What is the historical Revenue growth
over the last 5 years for Brain+ A/S?

What is the historical Net Income growth
over the last 5 years for Brain+ A/S?

What is the current Free Cash Flow
of Brain+ A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Brain+ A/S.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Brain+ A/S

Balance Sheet Decomposition
Brain+ A/S

Current Assets 6.3m
Cash & Short-Term Investments 4.7m
Receivables 1.6m
Other Current Assets -10
Non-Current Assets 31.6m
PP&E -3.6k
Intangibles 31.6m
Current Liabilities 4.5m
Other Current Liabilities 4.5m
Non-Current Liabilities 20.7m
Other Non-Current Liabilities 20.7m
Efficiency

Earnings Waterfall
Brain+ A/S

Revenue
1.8m DKK
Operating Expenses
-19.4m DKK
Operating Income
-17.6m DKK
Other Expenses
-2.5m DKK
Net Income
-20.1m DKK

Free Cash Flow Analysis
Brain+ A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BRAINP Profitability Score
Profitability Due Diligence

Brain+ A/S's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Negative 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
Negative ROE
18/100
Profitability
Score

Brain+ A/S's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

BRAINP Solvency Score
Solvency Due Diligence

Brain+ A/S's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
50/100
Solvency
Score

Brain+ A/S's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BRAINP Price Targets Summary
Brain+ A/S

There are no price targets for BRAINP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BRAINP?

Click here to dive deeper.

Dividends

Brain+ A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for BRAINP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Brain+ A/S

Country

Denmark

Industry

Health Care

Market Cap

16.9m DKK

Dividend Yield

0%

Description

Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. The firm focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. The company offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.

Contact

COPENHAGEN
Koebmagergade 53, 3rd floor
+4521754038
www.brain-plus.com

IPO

2021-10-07

Employees

-

Officers

Founder, CEO & MD
Mr. Kim Baden-Kristensen
Founder and CCO
Mr. Rasmus Højengaard
Interim Chief Financial Officer
Ms. Hanne Leth Hillman M.Sc.
Chief Technology Officer
Ms. Paula Petcu
Chief Science & Innovation Officer
Mr. Simon Nielsen
Marketing & Product Mang.
Mr. Bjarke Langbol Panduro
Show More
Chief Financial Officer (Leave of Absence)
Mr. Bertil Stengaard Jessen
Show Less

See Also

Discover More
What is the Intrinsic Value of one BRAINP stock?

The intrinsic value of one BRAINP stock under the Base Case scenario is 0.06 DKK.

Is BRAINP stock undervalued or overvalued?

Compared to the current market price of 0.102 DKK, Brain+ A/S is Overvalued by 41%.

Back to Top